ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve $100M Set Aside for Physical Sciences-Oncology Centers.

December 12, 2008

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010

FASEB: Focus on Research Funding, Not PR

June 14, 2013

NCI Plans Conference On DES Late Effects, Reproductive Cancers

November 29, 1991

Breast Density Does Not Raise Breast Cancer Death Rates

August 31, 2012

NCI Cooperative Groups Begin Trial Of Individualized Rx For Breast Cancer

May 26, 2006